PDCD5 and central nervous system cancer: Accumulating evidence indicates that expression of PDCD5 is downregulated in human cancer patients, specifically those affected by lung cancer, ovarian cancer, gastric cancer and glioma, suggesting that decreased expression of PDCD5 may be associated with the pathogenesis of human tumours16, 17, 18.